Bradford McRae
Senior Director - Immunology Translational Sciences, Gastroenterology Johnson & Johnson
Brad is an Immunologist with extensive pharmaceutical R&D experience. He has held various leadership positions within small molecule and biologics project teams from the exploratory phase through selection of development candidates and translational biomarker plans in early clinical development. He currently leads the Translational Sciences (TS) group for gastroenterology indications and is a member of the GI Disease Area Stronghold (GI DAS) for the Immunology therapeutic area at Johnson & Johnson.
Seminars
Wednesday 1st April 2026
Advancing IBD Therapy by Sharing New Clinical Insights & Future Directions of Recent Approvals
9:00 am
- Discover the latest clinical data and real-world insights to understand impacts on patient outcomes in Ulcerative Colitis and Crohn’s disease
- Learn how recent regulatory approvals are expanding treatment options and improving access for patients with IBD
- Explore future directions in IBD care by examining ongoing research, pipeline developments, and strategies for integrating new therapies into clinical practice
